Body Surface Gastric Mapping Vs Gastric Emptying Scintigraphy on Clinical Management in Gastroparesis

Launched by UNIVERSITY OF WESTERN SYDNEY · May 7, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating a new method called Body Surface Gastric Mapping (BSGM) to see if it can improve the management of patients with gastroparesis, a condition where the stomach takes too long to empty its contents. Currently, the standard test for diagnosing this condition is called gastric emptying scintigraphy (GES), but researchers are exploring whether BSGM, which uses a non-invasive device to assess stomach function, can provide better insights and lead to more personalized treatment options. The trial aims to determine if using BSGM alongside traditional methods can help doctors make more effective care decisions for their patients.

To participate in this study, individuals must be over 18 years old and have symptoms of functional dyspepsia or chronic nausea and vomiting, while also having a normal gastroscopy and a negative or treated H. Pylori infection. Participants will first undergo both GES and BSGM tests, after which healthcare providers will create a tailored treatment plan based on the results. Over the course of a year, the effectiveness of this BSGM-guided care will be monitored, including its impact on symptoms and overall quality of life. This trial could potentially change how gastroparesis is diagnosed and treated, making the process safer and more effective for patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged over 18 years old
• • Meeting Rome IV Criteria for Functional Dyspepsia and/or Chronic Nausea and Vomiting Syndrome
• • Referred for gastric emptying scintigraphy
• • Normal gastroscopy
• • Negative or treated H. Pylori status
• Exclusion Criteria:
• • Pregnant or breast-feeding
• • Inability to perform a BSGM test according to Indications for Use: history of severe skin allergies or sensitivity to cosmetics or lotions; chronically damaged or vulnerable epigastric skin (fragile skin, wounds, inflammation); unable to remain in a relaxed reclined position for the test duration.